<DOC>
	<DOCNO>NCT00002088</DOCNO>
	<brief_summary>To assess efficacy Saccharomyces boulardii ( nonpathogenic yeast ) produce significant reduction diarrheal symptom HIV-infected patient chronic diarrhea .</brief_summary>
	<brief_title>Treatment Patients With Human Immunodeficiency Virus ( HIV ) -Related Chronic Diarrhea With Saccharomyces Boulardii Placebo : A Double Blind Trial</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Antiviral medication HIV infection . Patients must : Documented HIV infection . Chronic diarrhea ( least 1 month ) either manifestation complication document HIV infection . Had stool culture ( Salmonella , Shigella , Campylobacter , Clostridium difficile ) stool analysis ovum parasite ( O/P X 3 ) within past 2 month . Failed antimicrobial treatment diarrhea OR receive prior antimicrobial stool pathogen stool culture negative . Patients antiviral medication HIV infection must receive medication least 2 week must remain stable dose week 1 2 study . Prior Medication : Allowed : Prior antiviral medication HIV infection ( medication , must receive least 2 week ) . Standard antimicrobial therapy document positive gastrointestinal pathogen . Exclusion Criteria Concurrent Medication : Excluded : Gastrointestinal medication cause diarrhea ( e.g. , magnesiumcontaining antacid , lactulose ) . Maintenance antifungal medication lifethreatening fungal infection ( fluconazole &lt; = 100 mg/day ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1996</verification_date>
	<keyword>Diarrhea</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Saccharomyces</keyword>
</DOC>